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DISSERTATION ABSTRACT  
Title: The cost of providing consultative palliative care services in a tertiary hospital setting 
 
Author: Linda Mbuthini (MBTLIN006),  
Supervisors: Ms. Lucy Cunnama, Dr René Krause, Prof, Jennifer Moodley 
 
Background 
The Sub-Saharan African region has sparse palliative care established to cater for patients facing life 
limiting conditions. In South Africa, costing frameworks for palliative care interventions for the public 
sector do not exist and the cost of running a comprehensive palliative care programme remains 
unknown. There are few costing studies to inform costs of palliative care models which are necessary 
for decision makers to base their decisions on. The aim of this study was to determine the costs and 
cost drivers for hospital based consultative palliative care service (HBCPCS) from a providers' 
perspective. 
Methods 
In this empirical costing study, we developed and utilized a costing tool that employed a mixed 
bottom-up and top-down costing method to estimate the incremental cost of an existing HBCPCS in a 
tertiary hospital in Cape Town, South Africa, called Groote Schuur Hospital (GSH) adopting a public 
provider perspective. All inputs where valued using bottom-up, ingredients-based methods, except 
for direct staff where a top-down approach was utilized to allocate the staff’s salary to palliative care 
services. We collected costing data by conducting inventory audits, key informant interviews and 
observations. All inputs required in the production of the HBCPCS were checked against a costing 
framework for economic evaluations of palliative care interventions to ensure that the cost estimates 
were as inclusive as possible. All inputs with a lifespan of more than one year were annuitized using a 





The total annual cost for running the HBCPCS was R2 494 419 including both recurrent and capital 
costs. Recurrent items alone accounted for 96% (R2 392 407). While, capital items accounted for 4% 
(R102 013) during the study period. The total cost per visit was R642 including the standard drug 
treatment package (R16). The major cost driver in the service was personnel, accounting or 91% of 
the total annual cost. While a scenario analysis shows that when the size of the team is double the 
current size then the cost of direct personnel would increase to R4.4 million. 
Conclusion 
We have estimated the incremental unit cost of HBCPCS to be R642 per visit, the major cost driver 
being personnel. If funding allows, with an annual cost of R2.4 million these services can be provided 
in a public tertiary hospital as an adjunct to inpatient care for patients as a strategy for integrating 
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South Africa (SA) is a middle-income country in the foot of the African continent, the second biggest 
economy in the region boosted by diverse economic activities(1) . However, there is inequity in 
distribution of health services(2). SA health care system is funded mainly thorough a tax-generated 
funding. A recent SA burden of disease study revealed that there are four broad categories of disease 
or conditions that are the leading cause of morbidity and mortality in SA. These broad diseases 
categories include; communicable disease (excluding HIV and TB), TB and HIV, non-communicable 
diseases and injuries(3). This disease burden puts strain on all components of health care; prevention, 
early detection, diagnoses, treatment, palliative care and survivorship (transition from treatment to 
extended survival)(4). However, there is little investments on palliative care.  
 
Palliative care is aimed at improving the quality of life of patients and their families who are facing 
problems associated with life-threatening illness, whether physical, psychosocial, or spiritual. The 
World Health Organization (WHO) defines palliative care as an approach that improves the quality of 
life of patients and their families facing the problem associated with life-threatening illness, through 
the relief of suffering by means of early identification and impeccable assessment and treatment of 
pain and symptoms, psychosocial and spiritual care(5). For many years palliative care has been 
perceived as the act of giving pain medication to sufferers of life-threatening diseases but instead 
should be seen as promoting dignity, quality of life and adjustment to progressive illnesses, using the 
best available evidence. The rationale for palliative care certainly includes the need for relief from pain 
and other distressing symptoms, but it goes further to include efforts to enhance the quality of life, 
and even influence the course of illness in a positive way(6). 
 
Patients in need of palliative care may require support from different levels of palliative care services 
during the course of their care, and it is important that there are referral pathways in place to ensure 
a seamless transition for patients and their families as well as providing these patients with quality 
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and effective services(7, 8). These categories of palliative care services are home based palliative care; 
mobile outreach services; outpatient care; inpatient palliative care facility; and consultative hospital 
based palliative care services from district level to tertiary hospitals. In a well-functioning system, 
there is a need for interaction and integration between these different levels of care(6, 9) 
 
World Health Organization (WHO) recognised importance of palliative care, especially in low- and 
middle- income countries (LMICs), it has passed a resolution to strengthen palliative care during the 
2014 World Health Assembly (WHA)(6, 7, 10). Furthermore, it has been recognised that palliative care 
services have not been incorporated into the main health care services in the various levels of the 
health care system in many countries. This is an injustice to the sick, frail and weak who are suffering 
from life threating comorbidities, who without palliative care are often left to die in suffering without 
dignity and care. Despite palliative care being recognised as a crucial component of the health system, 
there have been very few studies establishing the cost component of Palliative care services (PCS) in 
South Africa for decision making. 
 
This study will estimate the costs for consultative hospital based palliative care services (HBPCS). 
HBPCS are consultative services provided by a multidisciplinary palliative care team for inpatients. 
These services are provided through the following components of palliative care: identifying patients 
and continuity of care; symptom management; family support services; quality of life improvement; 
and end of life care. Each component has a requirement of resources, time and cost. In SA there is 
very limited generation of cost data relating to HBPCS. Due to improved life expectancy leading to an 
aging population in SA, it is expected that non-communicable diseases including cancer will raise. 
Therefore, – this increasing disease burden raises the need to integrate paliative care services ito the 
main health system services. This study will provide decision makers with cost components which can 




Palliative care services (PCS) maintain dignity and quality of life of sufferers. Health system reforms 
such as the re-engineering of primary health care (PHC) and introduction of National Health Insurance 
(NHI) aim to address the structural inequities of the health system and expand services coverage. The 
inclusion of PCS in the hospital-based services PHC is an essential move in responding to universal 
coverage which is a core concept of NHI. The need for PCS and palliative care education remains vital 
to contribute to the quality of life of patients, both adults and children in SA(11). 
 
It is understandable that health care systems in LMICs are under increasing threat due to stagnant 
revenues and increasing health care demands due to communicable and non-communicable disease, 
injuries and other comorbidities. “Increasing access to palliative care services in low- and middle-
income countries is often perceived as unaffordable despite the growing need of these services”(12), 
The South African Minister of Health, Dr Aaron Motswaledi, has demonstrated a commitment to 
PCS(13), but the pledge to make it work effectively must also come from varying levels within the 
Department of Health (DoH). An obstacle to overcoming this challenge is that palliative care as a health 
service has not been determined at all levels, currently there is no costing model in place(12). There are 
limited PCS costing studies that determines costs of all forms of palliative care services(12). This study 
aims to provide policy makers with the economic evidence to make optimal resource allocation 
decisions for HBPCS at a tertiary level in the Western Cape. This study will identify HBPCS, cost 
resources for this service and justify the funding requirements to sustain HBPCS in Groote Schuur 
Hospital (GSH).   
 




The aim of this study is to determine the costs and cost drivers for an existing hospital based consultative 
palliative care service (HBPCS) in South Africa adopting a providers' perspective. 
Specific objectives 
 
 To Identify and quantify resources needed in HBPCS in GSH 
 To cost each category of quantified resource 
 To develop a costing tool for HBPCS 
 To estimate the cost per patient for providing a HBPCS in a tertiary hospital in South Africa 
 To establish total operational cost for running HBPCS in a tertiary hospital in South Africa 
Conceptual Framework 
 
Figure 1: Conceptual Framework for costing HBPCS in Tertiary Hospital 
Palliative care is well placed in the continuum of care detailed in the National Policy Framework and 
Strategy on Palliative Care (NPFSP) 2017-2022(13). Palliative care services should be delivered by a 
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multidisciplinary team that will provide care that is respectful and responsive to individual patient’s 
preferences, needs and values and ensuring that patients values will guide clinical decisions. The aim 
and objectives of this study will be to identify resources required, quantify these resources and cost 
resources accordingly for HBPCS in a tertiary hospital. All costs will be added together to establish a 
total operational cost for running HBPCS in a tertiary hospital. This study will provide evidence that 
will be useful in informing resource allocations for integration of palliative care in the Western Cape. 
A palliative care patient is eligible for palliative care if they have been diagnosed with life threatening 
disease for which cure is not possible and require pain management, psychosocial care and spiritual 
care. Palliative care should not be seen only at the end of life in the disease trajectory, but it should 
be started together with curative care. The understanding is that the demand for palliative care will 
increase while the demand for curative care reduces over disease trajectory for patient diagnosed 
with life threatening diseases.  
Proposed Study Design 
This retrospective study will use a mixed method approach adopting a provider’s perspective to 
measure the incremental cost of an existing public HBPCS in a tertiary hospital. This study will cost all 
inputs including recurrent and capital costs associated to the consultative palliative care services and 
in-kind contributions (labour and non-labour). A combination of inventory audits, interviews and 
observations will be used to collect the necessary data based on palliative care services. These costs 
will be projected over the 2018/19 fiscal year. An annual cost per patient will be calculated using the 
unit costs generated and number of visits per annum per patient. The expenditure and budget item 
allocations for HBPSC in GSH will be sourced from Western Cape (WC) Department of Health (DoH), 
any other data will be collected directly within GSH. This study will be conducted in collaboration with 
the palliative care team at GSH and the Western Cape DoH who are in the forefront in implementing 




Study ethical approval will be sought from the University of Cape Town Human Research Ethics 
Committee (HREC). Once ethical approval has been obtained researchers will start to develop a costing 
tool in Microsoft Excel. This tool will be developed in consultation with the palliative care team in GSH 
and the Western Cape DoH. It will account for all recurrent and capital costs incurred in the delivery 
of HBPCS in GSH. An inbuilt formulary will be incorporated into the tool to summarize costs. This 
costing tool will list inputs and detail quantities including prices associated with every input to 
estimate the unit cost per patient and the total cost of the service. This HBPCS tool will be validated 
and tested prior data collection in GSH to refine the tool. All costs will be in South African Rands (ZAR).  
A sensitivity analysis will be conducted to assess cost differences in the case where the HBPCS is 
delivered by a comprehensive multidisciplinary team. This sensitivity analyses will be used to estimate 
the changes in the cost of the PCS given a change in the size of the team. The findings of this study will 
be used to advocate for resources for PCS in tertiary level facilities both in GSH and the Western Cape 
province(14, 15).   
            
Research Setting  
This study will take place at GSH where the consultative HBPCS are already in place. GSH is one of the 
Western Cape’s academic hospitals in Cape Town. The hospital is internationally renowned as the 
training ground for some of South Africa's doctors, surgeons and nurses(16) . GSH strives to provide 
outstanding tertiary care for patients of the Western Cape and beyond and has been one of the few 
facilities leading the implementation of PCS in the Western Cape. GSH is the only tertiary hospital in 
the Western Cape that provides a HBPCS. The patients seen by the palliative care team remain the 
responsibility of the admitting team (meaning that they remain the responsibility of the hospital ward 
in which they have been admitted), but are supported by the palliative care team through consultation 
for palliative care services(9). Eligible patients are identified using the Palliative care assessment tool 
(Appendix 3).  
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Possible Difficulties and Solutions 
It is understandable that some of the costing information will not be available at GSH. However, the 
Western Cape DoH should be able to provide researchers with actual and/ or estimates of cost 
information. Information on cost per personnel is considered confidential. Standard hourly rate for 
each pay class or category will be used to cost personnel instead of obtaining salary pay slips. All 
materials that are procured through the national government central supply database will be costed 
according to the actual purchase price listed in the central supply database understanding that these 
prices may differ from market prices.  
Ethical Considerations 
Ethical approval will be sought from the University of Cape Town Human Research Ethics Committee 
(HREC). This study will adhere to confidentiality, beneficence and non-maleficence considerations. All 
data that is collected will be stored safely and will only be accessed by researchers on this study. 
Anonymity will be maintained for all data regarding identity of staff and patients. There is no likelihood 
of any risks and dangers during this research study. Data on salaries will be reported by job title, 
patients seen in the study period will be head counted, these head counts will be used to estimate the 
average cost of care per patient. Researchers will use aggregated financial data, no pay slips, employee 
contracts, invoices or any proof of payments will be required, researchers do not foresee any harm 
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In many countries around the world, disease burdens continue to rise. This increase is attributable to 
improved life expectancy and many other factors which include socio economic conditions, unhealthy 
diets, sedentary lifestyles, and unhealthy behaviours(1). In addition, advancement in technology as well 
as improved diagnostics and data reporting provide us with an opportunity to better observe and 
understand disease burdens. The burden of diseases refers to an epidemiological observation of 
diseases that describes mortality and morbidity of major diseases and risks factors to health. This 
observation can be at a global level, national level or district level(2, 3). Health care systems in many 
countries are over stretched in response to increasing healthcare demand, resulting in a growing 
burden of communicable and non-communicable diseases. One of the main goals of healthcare is to 
cure diseases. However, a cure is not always possible, particularly in the current era of chronic 
diseases. In response to the need for comfort, relief from pain in chronic and life-threatening 
conditions for which cure is not feasible, palliative care emerged as an important consideration in 
healthcare(4).  The World Health Organization (WHO) defines palliative care as the prevention and 
relief of physical, psychological, social, or spiritual suffering experienced by patients living with life-
threatening health conditions. It promotes dignity, quality of life and adjustment to progressive 
illnesses, using the best available evidence(5). Palliative care has become a critical provision of health 
care especially in recent years due to life threatening conditions. With the current rate of observed 
burden of diseases, many people will be facing life-threatening diseases, injuries or life limiting health 
conditions and will require palliative care. Ideally, palliative care should be an important consideration 
for Universal Health Coverage and an essential service available to the whole population of a country 
without anyone suffering financial losses, neglect nor dying in seclusion. Despite this critical 




In recent years, palliative care has been highlighted as an important consideration to be placed on the 
agenda for decision makers. However, the challenges of limited health care resources remain. In the 
2014 World Health Assembly a resolution was adopted in which the WHO recommended that 
countries should facilitate the investment and integrate palliative care services in their respective 
health care systems(6). However, in sub-Saharan Africa there is slow progress towards the inclusion of 
palliative care services. There are numerous factors hindering palliative care in every corner of the 
world, these include funding, availability of specialists and training(7). The cost of proving palliative 
care at a population level has been one of the major barriers to access, particularly in resource-
constrained settings. However, there are a limited number of economic evaluations and evidence 
around costing of palliative care services in Africa which makes it difficult for decision makers to 
estimate how much these services cost governments.  
This literature review intends to map out and provide an insight into palliative care developments in 
Africa and describe factors influencing palliative care in this region. This analysis of the literature aims 
to identify studies describing costing approaches for palliative care interventions in sub-Saharan 
African countries and also to provide a brief evidence of the role of interest groups in achieving 
palliative care. Specifically, this review will aggregate evidence from relevant studies to provide an 
overview of costing considerations and costs for providing a palliative care in public hospitals in sub-
Saharan Africa and in South Africa to be specific.  
Domains of palliative care 
Palliative can be delivered in one of the three main domains 1) home-based/ home care, 2) 
community-based, and 3) health facility based. Alternatively, these domains can be offered in 
combination of two or more simultaneously depending on affordability to the provider(8, 9). These 
domains are described below: 
Home-based/ home care palliative care services: These are the services provided in the home where 
patients live with their loved ones. They are best delivered by a trained palliative care team of health 
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professionals. This approach is believed to be cost saving(10) in comparison to facility based palliative 
care models. In this approach of care family members are supported and trained in providing care, 
they are also integrated into the process and can facilitate referral to ancillary services, family 
members together with ward based outreach teams (WBOTs) ensure that their patient has easy access 
to care and their confidentiality and safekeeping is not compromised(11). There are some 
disadvantages in providing home-based care palliative care services such as the difficulty in providing 
home-based care in situations where all family members are fulltime workers and, in such situations, 
they can even be compelled to forfeit their income to look after their loved ones. Chronic conditions 
can be costly or even impoverishing should conditions require that fulltime workers quit work to take 
care of their health or their loved ones.  
 
Community-based services are sometimes referred to as hospice palliative care, are those offered by 
non-profit organisations, that are run by members of the community in local community health centres 
(CHC)(10). These services require community participation, involvement, commitment, and dedication 
to be sustainable. They comprise community involvement in all levels, community-based palliative care 
services rely on voluntary funding, in-kind contributions and sometimes are financed by or on behalf 
of the patients. They can be run in poor or resource intensive community settings as long the public is 
committed to pledge or donate resources to run these services. 
 
Health facility based palliative care services provide care for inpatients and outpatients. These services 
are rendered by trained palliative care professionals in health facilities such as clinics, hospitals and 
they sometimes require a multidisciplinary approach, specialists, and medical equipment to make the 
care more comprehensive. This approach of palliative care also facilitates a patient-centred approach 
which enables a smooth transition to care in the community and links patients to ward based 
outpatients teams (WBOT)(9, 10). Effectiveness and intensity of care in these approaches has been 
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studied in many settings. However, there is limited data on costing of these services, especially in the 
African region. Health facility based palliative care approaches can be classified as follows: outpatient 
palliative care clinic, hospital-based outreach palliative care, hospital-based consultative services, 
palliative care hospital day services and inpatient palliative unit. The palliative care clinic and the 
outpatient health facility based palliative care service reduces inpatient admissions which in turn 
reduces the provider costs but increases the rate of home deaths(12). In contrast, treating patients in 
facilities is believed to increase the cost and the load for providers(13). The consultative palliative care 
approach, where a palliative care multidisciplinary team of health professionals provide a consultative 
palliative care services to hospital inpatient admitted in different wards within the hospital is under 
studied with limited literature available.    
The global landscape of palliative care 
It was felt that palliative care was not getting the attention and the recognition from policy makers it 
that it required, and so there was an urgency to alert decision-makers, health professionals, and 
communities about the need of palliative care and its effectiveness(14). This motivated many different 
concerned parties to join forces in various settings in the world to lobby for the integration of palliative 
care and for it to be considered as important as any other public health issue. One of the important 
initial steps was to conduct a study to assess the distribution of palliative care services around the 
world. Evidence provided by Wright et al. in 2008(15) mapped palliative care provision throughout the 
world (Figure 1), during this period palliative care was mostly provided in high income countries (HICs) 
with abundant health care resources. While the evidence revealed the need for palliative care services 





Figure 1: World map showing the level of palliative care development directly from Wright et al. 
2008(16) 
 
Wright et al. in 2008(16) categorized hospice-palliative care initiatives in different countries around the 
globe, these initiatives were represented in world and regional maps using a mathematical algorithms 
that involved the analysis of evidence from different sources; published and grey literature, regional 
experts, and a task force selected from palliative care advocacy bodies(16). In this scoping review by 
Wright et al. palliative care interventions were identified in 115 of the total 234 countries originally 
included for study. The authors describe four categories that countries were assigned to, as follows: 
1) 33% had no identified hospice-palliative care activity; 2) 18% had capacity building activities but no 
palliative care services; 3) 34% of countries had localized palliative care provision; and 4) 15% of 
countries had palliative care activities approaching integration with mainstream service providers(16).  
 
This study showed disparities between LMICs and some of these were associated with the level of 
development of each country and the resources devoted to health care (especially for palliative care) 
in that country. Most of these palliative care interventions were provided by hospices, non-profit 
organizations, and the private sector. This study alone showed that palliative care awareness was 
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needed to bring attention, recognition and commitment of decision makers and advocates to facilitate 
palliative integration especially in the public health sector of many countries. This study by Wright et 
al. in 2008(16) was performed more than a decade ago, and subsequently, an important report was 
published by the World Health Organization (WHO) in 2014 titled "Global Atlas of Palliative Care at 
the End of Life". This report updated and refined the estimates made by Wright et al. 2008(16). 
According to this WHO report it is only 14% of the global population that has access to the highest 
standard of palliative care, and this access is more concentrated in European countries(17). Due to these 
disparities, palliative care advocates rallied forces behind the agenda of integration of palliative care 
services and its recognition globally(14). According to palliative care advocates, palliative care should 
include the dignity of the patient and the principles of urgency, universality and being non-
discriminatory. The international palliative care community is supported by three prominent 
disciplines: palliative care, public health and human rights, in which specialists in these fields interact 
on an ongoing basis and over various platforms to achieve this common agenda. The international 
palliative care community argues that “…the care of the dying is a public health issue. Given that death 
is both inevitable and universal, the care of people with life-limiting illness stands equal to all other 
public health issues”(14).  Given the low number of articles sources, there is a need for updated studies 
to improve the available evidence. 
The growing recognition of palliative care 
Palliative care started as a religious institutional practice and it further evolved and was deemed 
important by caregivers to provide care for patients with terminal illnesses. In recent years we have 
seen how it has added value in patients with life limiting conditions. Palliative care has now been 
recognised as a human right(18). This recognition was advocated by the global palliative care 
community on behalf of the weak and frail facing life limiting illnesses, who on their own cannot 
advocate for services they need. This achievement was realised after palliative care advocates, 
researchers and palliative care professionals around the world including Africa, joined forces to lobby 
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for the realisation of palliative care and its recognition as a basic human right over many efforts in 
various platforms. 
In 2002, the international community of palliative care drafted the Cape Town Declaration. This 
declaration articulated strategies, modalities, and essential principles to address the suffering related 
to life limiting conditions. This resolution endorsed palliative care as a basic human right for every 
patient facing a life limiting disease(19). This was necessary because palliative care is essential and 
central to health and human dignity.  Palliative care was endorsed for two reasons; 1) it does not foster 
or prevent death, but it provides effective response in alleviating suffering and pain ;2) it ensures that 
sufferers live active and pain free lives for as long they are alive. This resolution also endorsed 
availability of appropriate drugs such as opioids which was a challenge and limited in many African 
countries for many reasons, such as governments regulations put in place to avoid recreational use of 
opioids. Limited drug availability in many African countries can also be attributed to a low availability 
of specialist and doctors who are legally regulated to prescribing opioids in all levels of care. The lower 
levels of care are characterized by a sparse distribution of doctors making it difficult to access opioids 
in lower levels of care. For this reason, the resolution also endorses establishments of educational 
programmes for informal and formal providers of palliative care who are in the vanguard in delivering 
these services(19). In short the resolution endorses the integration of palliative care in all levels of 
health care.  
In 2005, the palliative care international community meet in Korea and drafted the Korean 
Declaration. The Korean Declaration(20) put emphasis on the major points articulated in the Cape Town 
declaration and further encouraged that all hospice and palliative care services should be included as 
part of all governmental health policy, as recommended by the WHO(6). Further, in 2007 the 
international community drafted the Budapest Commitments(21). The 
national associations of hospice and palliative care were developed further across regions and 
formulated what is known as the Worldwide Palliative Care Alliance (WPCA)(22). While, pushing the 
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same agenda over several mediums and platforms, WPCA supported the regional networks such as 
the International Association of Hospice and Palliative Care (IAHPC), the Asia-Pacific Hospice Palliative 
Care Association (APHPCA), the African Palliative Care Association (APCA), and the European Palliative 
Care Association (EPCA). These commitments called for extensive availability of patient centred and 
affordable palliative care services which are non-discriminatory. They further acknowledged that 
these services will be fostered through policies which will also consider primary health care principles. 
Lastly, these commitments acknowledged the lack of palliative care education and called for 
integration of palliative care education for informal education for caregivers and professional 
education for formal training of specialist. The biggest achievement of the forces behind WPCA was 
the World Health Assembly in 2014, where WHO recognised the worthiness of palliative care, 
especially in LMICs. In general, these resolutions aimed at fostering palliative care. 
Scoping for this review 
We consulted technical experts in the field of palliative care for their recommendation of several 
articles for inclusion in this study as a start set. Thereafter, a snowballing technique(23) for selecting 
relevant titles from the start set references list was undertaken.  Formal literature review was done 
additional to the snowballing technique, articles were searched in various databases: Google Scholar, 
PubMed, and Scopus. For inclusion, studies were reviewed if they included any of the following terms: 
“palliative care”, “development”,” “initiatives”, “goals”, “Africa”, “provider”, “challenges”, “end of life 
care”, “opioids”, “strengths” and “cost”. The focus of this literature review was on studies conducted 
in low- and middle-income sub-Saharan African countries. Therefore, studies were deemed eligible 
only if they were palliative care studies that originated in Africa or were scoping reviews that included 
palliative care developments in the African continent. Using the snowballing technique was 
advantageous because we identified relevant papers and then used these article to drive the literature 
identification forward from reference lists of identified articles(23). After the snowballing and database 
search, a total of 132 articles were identified. However, after thorough screening of these articles, we 
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excluded 78 which were duplicates or were not relevant to this study and a total of 54 articles were 
found to be eligible for the structured literature review. 
Figure 2: Preferred reporting items for systematic reviews and meta-analyses (PRISMA) Diagram  
Palliative care services in Africa 
A comprehensive scoping review study on palliative care was conducted between 2005-2016 for 26 
African countries by Rhee et al. 2017(15). This study assessed medical literature and included articles 
recommended by a local expert, published in four common languages. It sourced articles that 
articulated or mentioned: activities, policies, medicines, implementation, or advocates in palliative 
care. Selected articles had to meet a quality assessment criterion which was based on: 1) the journals 
impact factor, 2) journal ranking, 3) number of citations per article. There were 518 articles found 
(South Africa alone contributed a total of 210 articles) but only 49 of these articles met the quality and 
assessment criteria. Information on 26 (48%) of 54 African countries was found. Most services were 
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concentrated in Kenya, South Africa, and Uganda, and 14 (26%) countries showed an increase in 
palliative care services during this timeframe. Stand-alone palliative care policies were existing in 
Malawi, Mozambique, Rwanda, Swaziland, Tanzania, and Zimbabwe. Postgraduate diplomas in 
palliative care were available in Kenya, South Africa, Uganda, and Tanzania(15). Prescriber restriction 
laws, restrictions and access to opioids were identified as common barriers to adequate palliative care 
provision. Information on service provision and implementation was available for 19 countries with 
Kenyan, South Africa, Tanzania and Uganda and Zimbabwe with highest number or activities of 
palliative care services(15). This study argued that “…availability of medicines remained a major issue 
across African countries, with access to morphine being a notable change, although opioid availability 
is not the only aspect of palliative care development”(15). This study showed that information on 
palliative care development was concentrated on a subset of countries and that palliative care 
advocates should not only focus on scaling up services and medicines but should also focus on 
improving palliative care polices, education and research. It is important when evaluating palliative 
care to consider not just service provision, but focus be paid to; policies, implementation, drug 
availability such as opioids, education, interventions and services providers.  
Palliative care services in Africa remain insufficient, there are a number of strategies that can be used 
to harness these services and facilitate greater service coverage(24) and palliative care services in the 
African region need to be enforced to address the rising demand placed by burden of diseases(25). Two 
studies by Allsop and colleagues in 2018 and 2019(24, 25), argue that mobile Health (mHealth) 
interventions should be explored even further to archive wider coverage and access to palliative care 
for patients with life threatening conditions. These interventions include mobile phone applications, 
inbound and outboard call centres, and text messaging to educate or empower caregivers and patients 
with health education. Allsop et al. 2018, conducted a systematic review to identify the development 
and use of mHealth in palliative care services in sub-Saharan Africa. The authors plotted identified 
mHealth interventions against a modified WHO mHealth and information, communication and 
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technology (ICT) framework to classify how they are targeting health system strengthening(24). In total 
there were 110 articles identified, but only five of these articles met the inclusion criteria. These five 
articles describe mHealth interventions for palliative care services use in Nigeria, Uganda, Kenya and 
Malawi. However, there was no evidence of mHealth services in South Africa, which might be due to 
the lack of scientific documentation and publication relating to palliative care mHealth services. The 
second study by Allsop and colleagues in 2019, focused on the use of mHealth interventions in sub-
Saharan Africa in reaching out to affected populations(25).  mHealth interventions are not a widespread 
model for provision of palliative care services and are under studied. Advancements in technology 
provides an appropriate opportunity to scale up provision of palliative care intervention such as 
mHealth and call centres to reach the marginalized population living in the outskirts of city centres. A 
full costing of these mHealth interventions would be useful to provide supplementary evidence for 
feasibility and decision making. However, palliative care models are under researched in their entirety. 
Subsequently an online survey was conducted in 21 countries in the African continent to identify: 
current mHealth use in PC service delivery; potential barriers to mHealth use; and provider priorities 
for research development. There were 51 services identified throughout the region, only 74% of these 
services responded to the survey23). This online survey identified that there were barriers to mHealth 
which included “…not having access to phones, mobile network access, and limited access to expertise 
and hardware required for mHealth” and “…research priorities were identified which included 
exploring ways of incorporating mHealth into patient care and ensuring access and relevance of 
mHealth for patients and health professionals”(25). Both these studies (15, 25) shows that mHealth 
palliative care services were present in Africa but so were barriers to accessing these services and that 
evidence-based mHealth interventions could form part of the evolving palliative care services in 
Africa(25). The lack of basic infrastructure is notably the biggest challenge in exploring mHealth 
interventions in Africa. 
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The delivery of quality health care services is an important consideration of health care in any country. 
With the resolution of the WHO in 2014, palliative care has also been included as part of essential 
health services especially in low- and middle-income countries facing a quadruple disease burden of 
communicable and non-communicable diseases(6). As we move to Universal Health Coverage the need 
to integrate palliative care services should be realized. Therefore, it will be necessary that all medical, 
social, and spiritual carers who forms part of the delivery of palliative care health services acquire the 
right skills to effectively deliver quality palliative care services that meet the needs of people facing 
life threatening conditions. A palliative care steering committee assembled in 2014 in Ireland 
developed a palliative care competency document(26). This document aims to foster professional 
development of professionals who are in the forefront of the implementation of palliative care policies 
and identifies needs relating to these services. According to this document competences are generally 
a dynamic combination of knowledge, understanding, skills and abilities necessary to all palliative care 
teams. All of these are essential in any discipline however are especially important in palliative care 
service delivery. The only unfortunate part of this detailed competency framework was that it did not 
provide cost requirements for palliative care teams competencies.  
Factors that influence palliative care development Africa 
There are notable factors that enable advancement of palliative care. Conversely, there are also 
factors that hinder the advancement of palliative care. These factors may be different in different 
regions in the world, but they appear to be more remarkable in sub-Saharan African countries (14).  The 
ideas to introduce of Universal Health Coverage has provided an opportune moment to develop and 
integrate palliative care in the general health care services. The establishment and existence of 
advocating bodies and pioneering organizations have also played a role in achieving the development 
agenda of palliative care in many countries. Palliative care development refers to processes, 
structures, policies and resources that support the delivery of palliative care(7). Rhee 2018 et al.(14) 
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described four factors (drivers, strengths, challenges and aspirations) influencing palliative care 




Figure 2: Factors affecting palliative care development: Adopted from Rhee 2018 et al. (7) 
 
As indicated in Figure 3, ‘strengths’ refer to the factors that enable the implementation of palliative 
care services, they included workforce, diversity and the depth of services, research and palliative care 
education. These are inputs that are critical when delivering palliative care services for a population, 
they are mainly the building blocks of the actual services. In countries that already have plenty of these 
resources, structures and trained health care workers are more likely to succeed when implementing 
a palliative care service than countries with fewer of these inputs. Therefore, ‘strengths’ provide an 
enabling environment in rolling out and implementing a palliative care service. However, ‘strengths’ 
are more likely to be informed by ‘drivers’.  
‘Drivers’ refer to the activist and the pioneering organizations who mobilize, advocate and lobby for 
palliative care resources, policies and services. Often, ‘drivers’ meet to form alliances to add power to 
their voices and they set the agenda and put all their weight behind it. Countries with active activists 
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and pioneering organizations are better off in terms of achieving palliative care expansions than those 
with passive advocates. Sometimes ‘drivers’ can be in the form of human forces and interactions 
behind certain policy agendas or shared goals such as efforts to combat diseases which pose risk and 
place burden on health systems like HIV/AIDS. Establishments that were formed to combat other 
diseases can also be used to achieve palliative care advancements and ‘aspirations’.  
 
‘Aspirations’ are the desires, hopes and ambitions to archive short- and long-term goals. The most 
prominent goal in palliative care is integration of palliative in all levels of health system. This goal was 
articulated in the World Health Assembly in 2014. However, ‘aspirations’ are more likely and easily 
attained when working in partnerships with other stakeholders. Partnerships ensures continuity and 
sustainability of health care services. A good example is when local non-profit organization are 
working hand in hand with government to provide holistic palliative care services such as when 
patients are discharged from tertiary or district hospitals that they can still access palliative care 
services within their communities and hospices. Having strong partnerships with all stakeholders 
(Department of Health, pioneering organizations and the private sector) also strengthens health 
services delivery. One of the most desired ‘aspirations’ in palliative care is permitting nurses to 
prescribe opioids for palliative care to allow patients to access drugs for symptom management at all 
levels of health care. However, more efforts are still needed to promote this idea especially in sub-
Saharan African countries.   
Very importantly, lack of availability of palliative care education; lack of standardization in 
implementation; limited availability or accessibility to pain management medication such as morphine 
and other opioids; poverty; disease burden and inadequate funding are persistent ‘challenges’ for 
many Africa countries(7). Funding is required to ensure sustainability and to maximize existing 
resources to improve and expand services and infrastructure. Increasing access to palliative care 
services in African countries is often not a priority, even though people suffer, die in pain and with 
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minimum effort invested into palliative care. There are a limited number of economic evaluations and 
costings of palliative care interventions and health care services in the African region generally. The 
lack of these economic evaluation for palliative care interventions creates a perception of 
unaffordability, this perception creates a disregard of palliative care services which further creates 
inequities in health care delivery especially for those patients who are suffering from life threatening 
conditions. Health care decisions should be based on: scientific evidence; use near real time clinical 
and costing data; and be based on patients values and preferences to improve transparency of 
reasoning behind policies that are aimed at improving quality of care, health care outcomes and 
treating all people with dignity(27).   
There is an increasing demand for palliative care in sub-Saharan Africa, while access, availability and 
provision of services remains dubious and inadequately integrated into the national health services. 
In many African countries palliative care is largely reliant on missionary hospitals and non-profit 
organizations characterized by sporadic home-based care services. There are ongoing efforts to 
integrate palliative care into the general health services in these countries ever since the World Health 
Assembly in 2014. However, for integration to be successful there is a need to develop public health 
polices and public financing to sustain these programmes in Africa(8). Furthermore, there is a need to 
invest in costing studies for palliative care in order to understand the cost component for providing 
these services. Costing studies for palliative care services can contribute greatly by providing 
information needed to make policy and program decisions.  
Interest groups and their roles in achieving palliative care 
In many developed and developing economies, aspirations to achieve palliative care have been driven 
successfully by interest groups (activist and pioneering organizations). In Kenya, the hospice 
association at the national level has lobbied, advocated and mobilized for the integration of palliative 
care(28). The main aim was to ensure that all citizens who needed these services had access to palliative 
care close to their homes. The successful integration of palliative care has also resulted in: many health 
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care professionals being trained in palliative care, integration of palliative care in public, private and 
mission health institutions and integration of palliative care in undergraduate medical and nursing 
studies(28). Stakeholders involved in integrating palliative care were supportive throughout the levels 
of implementation as required. If Kenya has succeeded in integrating palliative care into the main 
health system, why would it be difficult to attain the realization of palliative care in South African. 
Many specialists and hospices in South Africa are members of the Hospice Palliative Care Association 
of South Africa (HPCA) which is also a member of the World Palliative Care Association(29). Members 
of these alliances are advocates and come from various fields and specialization in palliative care such 
as academia and medicine. Therefore, they have the necessary power to drive the agenda, they are 
trained in palliative care service delivery and have the necessary experience in implementation and to 
incorporate palliative care education into the curriculum of various training institutions. 
 
In Tanzania, there were several challenges in implementing the palliative care programme, these 
challenges were not unique, but common to other African countries(30). They included limited 
accessibility to morphine (one of the common opioids used) and workforce. There were many lessons 
that were learned throughout the integration process in Tanzania. However, the main objective was 
achieved because there was a rapid scale up of palliative care services to individuals in poor settings, 
improved palliative care training for health care professional and there was an observed increase of 
patients receiving palliative care services. Going forward it would be useful for African countries to 
learn from the experience of other African countries that have rolled out palliative care programmes 
successfully. More economic evaluation studies and health impact analyses exercises are useful and 
should be undertaken to evaluate effectiveness of palliative care modalities in African countries. 
 
Palliative care advocates are an important consideration in lobbying and mobilizing resources, 
especially when they are directly involved in agenda setting. They have the potential to assert pressure 
in the decision-making structures especially when they have one voice.  
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Accessibility and use of opioids in palliative care 
Patients who are weak, frail and facing life-threatening illnesses often require opioids for pain, which 
is a common feature of palliative care(31). Palliative care patients require clinical pain management 
through drugs such as opioids to; relieve pain; improve physical comfort; and enhance quality of life. 
Opioids targets the nervous system to reduce pain, they are commonly used in palliative care. In 
countries with intensive palliative care programmes there is large scale use of opioids. Equitable 
access to opioids is a major issue in many places in the world. About a quarter of the world's 
population (84.25%) lacks sufficient access to opioid drugs. More than 90% of global opioid intake was 
accounted for by Australia, Canada, New Zealand, the United States, and other European countries, 
while LMICs accounted for the remaining 10%(17). . The many reasons that hinder opioids use include 
insufficient knowledge and training of medical professionals in pain management, fear that patients 
may become addicted, and legislative frameworks for control of opioids use in various countries. There 
are enormous challenges that are associated with morphine restrictions, distribution and use 
worldwide, these challenges present inequalities in the distribution of opioids between HICs and 
LMICs.  
There are however countries that have archived a better rollout than others in Africa such as Uganda. 
Uganda has achieved a morphine roll-out programme in partnership with the palliative care interest 
groups in Uganda. A study was conducted in Uganda to evaluate the use of morphine for AIDS and 
cancer pain relief(32). Researchers employed different data collection techniques in three phases to 
follow distribution of morphine and its use from production throughout the supply chain. These data 
collection techniques included interviews, observations, and clinical care audits in two palliative care 
facilities. Health care professionals, carers and government officials were interviewed to describe local 
prescribing guidelines, and morphine distribution was observed from entry into Uganda throughout 
pharmaceuticals and distribution into state hospitals, wards, and patients in their homes. While the 




Results of the study shows that the model and the rollout of opioids offered a successful approach for 
patient care in Uganda. This study also tells us that advocates lobbied for relaxation of opioids 
regulation to improve accessibility and their use in which in turn benefitted palliative care patients 
allowing them to have quality life in their last days of life(33). This model was a good reference case for 
other countries in Africa. Subsequent to this study we have seen many countries developing guidelines 
for opioids use South Africa being one of them. South Africa developed a guideline for opioids which 
aimed at assisting health care professional to screen, select, and initiate patients on pain management 
and further monitor and continue opioids use. These guidelines further took experience from other 
international guidelines(31, 34-36) to make it as comprehensive as possible.  Today in South Africa pain 
management treatments can be prescribed from the Chronic Non Cancer Pain Guideline(37) or the 
WHO Model List of Essential Medicines(38). The WHO guideline has a more comprehensive list.  
Countries can develop their own opioids guidelines and recommendations, and in their 
recommendation, they can use drugs that are effective but easily accessible and afforded. Opioids are 
an important feature in palliative care, they are being used to treat and relive chronic pain and they 
improve the quality of life of palliative care patients(37). They are effective therapy in palliative care, 
their availability and use depict the quality of palliative care services in every setting, they can be used 
as indictors when monitoring palliative care services. Countries with eased opioids regulation are 







Table 1. Opioids Recommended in South Africa taken directly from the Chronic Non Cancer Pain 
Guideline  and WHO Model List of Essential Medicines(37, 38) 
Recommendation for Chronic Non Cancer Pain 
Guideline  
Recommendation of the WHO Model List of 
Essential Medicines  































Palliative care as an essential component of health care in SA Palliative care services in South Africa 
require urgent consideration because of the demands that are being placed because of an ageing 
population and the disease profile found in the country. When people grow older in a population it is 
more likely that they suffer from non-communicable diseases and other chronic conditions. With 
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these reasons among others palliative care should be an essential component of healthcare. Making 
palliative care a requirement for health care should include extending palliative care services to all 
eligible patients including people with non-cancer diagnoses. To determine whether palliative care 
should be an essential component of healthcare in South Africa, we have reviewed current evidence 
from the literature which we present here. 
 
A study by Frankenfeld et al. 2019(39) found that 14.6% of all patients over the age of 18 years, that 
were admitted to 46 acute care public hospitals medical and surgical beds in the Western Cape 
Province of South Africa, died within one year of hospital admission. The mortality ratio was 1 in 5 of 
patients admitted to medical wards and almost 1 in 10 patients admitted to surgical beds die within 
one year. The greater percentage of deaths in patients admitted to medical beds was likely a reflection 
of the natural burden of disease in South Africa, with death predominantly due to both non-
communicable and communicable diseases and this mortality was found to rise abruptly with age. 
This study revealed that patients admitted to specialised oncology beds, and those admitted to 
specialised tuberculosis hospitals had very high one-year mortalities of 50.8% and 29.9% respectively. 
This study used a Gold Standards Framework (GSF) prognostic indicator criterion(40, 41) for assessing 
palliative care need at a population level based on patient diagnoses and a retrospective approach of 
analysis of the one year post admission death registry data. The GSF tool criteria identified patients 
who are in their last year of life (retrospectively), it also assessed current and future (ahead in time 
while they are still alive), clinical and personal needs and plans across care in their final days.  
 
The findings of this study reveal that there is a great need for palliative care in South Africa, 1570 
(14%) of 10 761 patients admitted for acute care in 46 hospitals in Western Cape over a 2-week period 
in March 2012 died, also to take into consideration that this was just one of the nine provinces of 
South Africa, if the same methodology could be replicated in all provinces, we would likely see similar 
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results. This was the first study in the African context providing this kind of evidence and it reveals 
that a high portion of patients who are admitted in the Western Cape acute care hospitals are in their 
final year of life. Another related assessment of palliative care need in South Africa provided similar 
findings(42). Therefore, these findings suggest an investment into palliative care especially for those 
terminal disease condition such as cancer, TB and HIV based on need. Admission of patients into 
hospital may provide an opportune time to initiate palliative management for eligible patients. 
However, when they are discharged community WBOTs together with families can take over the 
management of these patients in the comfort of their homes.  
Cost of providing palliative care services within the public sector of 
the South African health system 
There was only one study that was identified in the sub-Saharan African region, this study was 
conducted in South Africa and it attempted to cost palliative care services in the public sector. The 
identified study used a gross costing approach which is known to have a poorer level of precision. In 
this study researchers attempted to measure the unit cost (cost per visit) for a hospital based outreach 
program(13). In this study a total of 4493 and 3412 in hospital visits and outreach visits respectively 
were recorded. The costs per hospital outreach visit and in-hospital visit were R568 (US $71) and R640 
(US $80) in 2011, respectively. This study found that hospital outreach services have a potential to 
avert hospital admissions in generally overcrowded services in low-resource settings and may improve 
the quality of life of patients in their home environments(13). To our knowledge there has never been 
a study conducted in South Africa with a focus on costing other modalities of palliative care. While 
there are extensive costing and cost effectiveness study that we have seen in first world countries 
such as US, Canada, China and the United Kingdom. (43-46). This gap highlights a need for further 
investments in research in palliative acre in the African continent. An important principle in Universal 
Health Coverage is ensuring that those needing care get to access the services they need whenever 
they need them. Specialists in palliative care understand that when rolling out a national 
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comprehensive programme for palliative care these domains of 1) home-based/ home care, 2) 
community-based, 3) health facility based or 4) informal care can be delivered individually or in 
combination. So, investment into costing studies for these palliative care domains would help 
determine the cost of each and depending on the country’s commitment to palliative care which 
domain could be affordable.  
Integrating palliative care with community health workers 
programmes in South Africa 
CHWs sometimes referred to WBOTs have been utilized in many countries to deliver outreach 
programmes such as: case finding, health education, home-based care, directly observed treatment 
strategies and other health services to patients in the comforts of their homes. These programmes 
have shown to have the potential to improve health outcomes in different settings and they have 
benefited those who are frail and living in areas that are difficult to access. An evaluation of CHWs 
investment for different health conditions was conducted in 2018 in South Africa for different diseases 
conditions such as: palliative care, HIV/AIDs, diabetes and hypertension and mother to child services. 
A South African Medical Research Council (SAMRC) working paper(10) reported the results of the 
investment case specifically looking at the costs and benefits in standard care scenario to a scenario 
of well performing CHWs platforms that are supported with adequate training, supervision, support  
and funding to achieve palliative care objective and other conditions. This study estimated that 1 out 
of 6 beds in the Cape Metropole alone are occupied by patients requiring palliative care and 50% of 
these patients are hospitalised for an average of two weeks. Therefore, when extrapolating to the 
population of the country the results shows if the 50% of the patients hospitalized were managed by 
WBOTs, 88 290 hospitalization would be avoided a year using the average hospitalization of two 
weeks. Daviaud et al.(10) further argues that for the same two weeks, palliative care at home would 
require one outreach visit by a doctor, an average of six visits by a professional nurse and eight visits 
by a community health worker. The yearly cost of home-based care, professional palliative clinicians 
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and community health workers visits, would be R331 million, whilst it would have been R3.7 billion if 
managed in hospital. About R3.3 billion a year would be saved, or R29.3 billion over 10 years. There 
are however a number of assumptions made in this modelling. Such as patients requiring the same 
intensity of visits and that all patients would require a standard visit by a professional doctor over a 
defined period. Doctor led programmes are also more expensive than nurse led interventions.  A full 
costing study for CHWs programme in palliative care would be very valuable. And it is important to 
remember that as much as the cost of providing the services is important the dignity provided to the 
patients and effectiveness of service is more important. There is no one better model of providing 
palliative care hence more of these models should be costed to provide costing data that can be used 
to determine what programmes are more effective when provided simultaneously in a comprehensive 
palliative care programme.   
Important consideration when conducting a costing study in 
palliative care 
It is very essential to examine the approaches that are used to generate data for estimating the cost 
of providing any services. There are various approaches in costing which include bottom up costing, 
top down costing and mixed approaches(27, 47). The precision of these costing approaches varies, micro 
costing commonly known as a bottom-up approach have a higher level of precision and because of 
this high precision the findings of the study can be very accurate about the costs of a service. The 
micro costing approach follows a bottom-up costing technique and uses an ingredient approach to 
identify, quantify, and cost inputs for a service. Due to these reasons micro costing approaches are 
quite expensive in comparison to gross costing approaches, as they are resource intensive. Gross 
costing approaches have a poorer level of precision. The assumptions made in a gross costing may 
affect the accuracy of the cost estimate, as this as well as the reliability are highly dependent on the 
quality of secondary data(47). For this reason, top-down costing studies are not appropriate measure 
of small changes in resource consumption. The gross costing approach follows a top-down costing 
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technique, they can be easily conducted and are less expensive. Micro costing and gross costing 
approaches can also be used in combination to archive different objectives.  
 
There are a very limited number of economic evaluations for palliative care domains (1) home-based/ 
home care, 2) community-based, or 3) health facility based Further research is required in this field to 
cost palliative care domains as discrete elements of care. These studies would produce cost evidence 
and frameworks that would reflect the full resource outlays and which can be adopted for future 
use(48). It is imperative to have good costing data for palliative care interventions in order to inform 
decisions regarding resource allocations for palliative care services. Gardiner 2017 et al.(48), conducted 
a systematic review study to understand what resources (inputs), components are relevant for 
economic evolution of palliative care, in this systematic review study articles were selected based on 
distinct search terms followed by screening of abstract and screening of full articles. For this study, a 
total of 38 research papers met the inclusion criteria. However, only eight studies were finally included 
in the analysis. This review summarised studies to explicitly group components of cost according to 
type of costs and domain of palliative care. Table 2 below presents a summary of inputs costs for 
different domains of palliative care. This framework is helpful to guide researchers about types of 










Table 2: Framework by Gardiner et al. outlining types of costs for different palliative care domains(48) 
 
Palliative care domain Types of costs 
Health facility based - Hospital 
Inpatient hospital admissions/bed days 
Personnel costs 
Medical supplies, equipment and aids, etc. 
Inpatient procedures (surgery, chemotherapy, etc.) 
Investigations, laboratory and diagnostic costs 
Drugs and medications 
Outpatient hospital admissions 
Emergency room visits 
Ambulatory costs and transport 
Hospital day care 
Outpatient procedures (chemotherapy, etc.) 
Chinese and herbal medicines 
Overhead costs (building costs and capital 
depreciation) 
Palliative care unit admission 
Palliative care outpatient clinics 
Palliative care consultative service 
Home-based/ home care 
OR 
Community-based  
General practitioner/family physician surgery visits 
Medical and nursing home visits (general 
practitioner, etc.) 
Allied health home visits (physiotherapy, 
occupational therapy, mental health) 
Other home visits (social services, home care, other 
careers) 
Drugs and medications 
Medical equipment, aids and adaptations 
Day care services 
Transportation 
Stays in long-term care facilities, care homes, nursing 
homes, skilled nursing facilities 
Transportation 
Diagnostic tests, laboratory costs 
Personal support (bathing, feeding, dressing, home 
help) 




Residential respite care and rehabilitation 
Overhead costs 




                                                                                                                                                 Continued  
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Palliative Care Domain Types of costs 
Hospice and specialist palliative 
care 




Investigations, laboratory and diagnostic costs 
Drugs and medications 
Equipment and aids 
Outpatient appointments and clinics 
Home hospice 
Home visits from specialist palliative care 





Equipment, aids, home adaptations 
Medications 
Insurance payments 
Travel and accommodation expenses 
Out-of-pocket expenses (parking, food/drink) 
Income lost from work 
Caregiver time costs 
Co-payments, e.g., shared with insurer/other 
 
The Gardiner et al.(48) study is important in guiding health economists who conduct costing for 
palliative care interventions, as it explicitly describes inputs that should be considered and that are 
relevant for different domains of palliative care programmes. The results suggest a framework for 
identifying inputs that can be considered in three key domains of palliative care: (1) home-based/ 
home care, 2) community-based, or 3) health facility  and further emphasized that the most important 
decision to make when conducting a costing study is deciding which perspective to adopt(48). There 
are generally three perspectives to adopt when conducting a costing study:1) public provider 
perspective, in this perspective the state uses effective financing mechanisms to pool funds and use 
these funds to purchase services on behalf of the population. 2) the individual or household 
perspective, in this approach the patients or their households bears the cost of consuming the services 
and 3) the societal perspective, in this approach all actors in the production and consumption of 
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service bears the cost of the services. These choice can mean a lot in the analysis of the costs and can 
have a great influence in decision making(49).  
Considerations for ensuring quality and accuracy for a costing study  
Costing studies like any research study must ensure that the findings are accurate and are of high 
quality. It is the aim of every researcher to produce cost estimates that are close to reality. In costing 
all identified resources utilised should be quantified and costed. To produce a quality costing output 
requires researchers to access several provider and patients’ records. In addition, seeking the opinion 
of experts, health professionals and the patients as well as the carers is very useful. These experts are 
specialist and agents in the policy implementation and their experience is useful in guiding researchers 
to develop a costing framework. In the study methodology section of the proposed study, we have 
indicated that service provider such as nurses, auxiliary workers and doctors who work in the palliative 
care service will be interviewed and will assist researchers in the identification and costing of all 
resources. According to Yazback 2001(50) to consider very importantly methodological issues such as 
measurement techniques, costing perspective and time horizon in order not to deviate from costing 
principles. Researchers need to carefully construct and identify clear aims and objectives of the costing 
study, this is very helpful in constructing realistic questions that will guide researchers to achieve the 
research objectives in a more answerable and measurable manner.  
 
The selection of the methodology should match the objectives of the study. It should be indicated 
clearly in the study the suitability of the methodology for calculating associated costs. The selected 
methodology should be able to identify and quantify all resources to establish a cost for the 
programme. The study should adopt a perspective of the costing procedure to have a clear understand 
of who is bearing these costs. The time period for the costing analysis should be clearly defined and 
be realistic, if costs are converted the conversion of currency should be clear, and amortization of 
resources that have a life expectancy of more than one year should be accounted for.   Researchers 
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need to use a tested or a realistic data collection tool, the data collection tool should account for 
recurrent and capital costs and should aspects of these not be accounted for then there should be a 
tangible reasoning as to why. The costing study should try as much as possible to take advantage of 
all data sources, so that the findings and results can be as close to the truth as possible. If any 
assumption is made, it should be stated explicitly so that everything is clear to the reader. Sensitivity 
analyses should be conducted to test robustness of assumptions and the findings should be presented 
very clear.  
Conclusion  
Literature suggest that palliative care services are widely adopted in developed countries, while they 
are significantly lagging in low resource countries. It has been estimated that inpatient services alone 
are available in about two-thirds of all hospitals in developed countries(51). Research in developed 
countries has demonstrated improved quality of life for palliative inpatients for symptom control and 
satisfaction with care(52). Due to these inpatient palliative care services families have benefited from 
emotional support, care planning and transitions of care. The outcomes of palliative care services 
including reduced hospital length of stay, hospital costs, and improved discharge status. Palliative care 
services have the ability to improve quality of life and avert hospital admissions(13). While palliative 
care for patients hospitalized with advanced disease results in lower costs of care and less utilization 
of intensive care(53, 54). However, there is scant literature on direct comparison on cost effectiveness 
of these palliative care domains or modalities. These domains are complimentary to each other, 
however when offered in combination they would be very resource intensive and unaffordable to low-
income countries. In addition, there is no single domain that has been proven to be more effective 
than the others. Research is required to provide costing models for palliative care in general and to 
support such evidence with effectiveness of palliative care programmes in conjunction with cost of 
providing these services.  Palliative care is under-researched in Africa and due to the demand placed 




Sub-Saharan Africa, in a setting of scarce resources and high disease prevalence will need to scale up 
palliative care services and integrate palliative care into the general health services. Palliative care 
services are essential especially to those facing life threatening disease conditions, and yet there are 
very few studies that has been done in sub-Saharan Africa to show how to incorporate these services 
in public health care systems. Instead palliative care services are perceived as costly and unaffordable 
even though there is very limited literature around their costs, which can be a barrier especially in 
decision making(27). Palliative care is in its infancy in Africa, there are attempts to drive the palliative 
care agenda in South Africa, especially around palliative care education, advocacy and drug 
availability. However, South Africa is lagging in terms of funding, standardizing and integration of 
palliative care services within the general health care in the country. Challenges associated with 
palliative care development are common in many African countries and they include: lack of funding; 
education; lack of standardization in implementation; reduced access to and availability of morphine, 
poverty and disease burden. In a country with influential advocates and advocacy groups some of 
these challenges can be addressed.  
 
In conclusion, during the time of this review there was only one study that identified full cost of 
hospital based palliative care services in the public sector in sub Saharan Africa(13). Many studies at 
end-of-life care in this region focused rather on costing specific disease conditions which do not reflect 
the full cost of palliative care services. We have seen middle income and higher income countries 
outside of the sub-Saharan region conducting full economic evaluations mainly  for three palliative 
care domains(55-57),  countries with health economics as an established discipline such as Canada, 
Turkey and Hong Kong having more robust studies in this filed.  Insufficient costing evidence in the 
African region makes it even difficult for decision makers to even consider palliative care. However, 
this lack of cost data highlights the need for the proposed study which will assess a consultative 
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The Sub-Saharan African region has sparse palliative care established to cater for patients facing life 
limiting conditions. In South Africa, costing frameworks for palliative care interventions for the public 
sector do not exist and the cost of running a comprehensive palliative care programme remains 
unknown. There are few costing studies to inform costs of palliative care models which are necessary 
for decision makers to base their decisions on. The aim of this study was to determine the costs and 
cost drivers for hospital based consultative palliative care service (HBPCS) in South Africa adopting a 
providers' perspective. 
Methods 
In this empirical costing study, we developed and utilised a costing tool that employed a mixed 
bottom-up and top-down costing method to estimate the incremental cost of an existing hospital 
based consultative palliative care services (HBCPCS) in a tertiary hospital in Cape Town, South Africa, 
called Groote Schuur Hospital (GSH) adopting a public provider perspective. All inputs where valued 
using bottom-up, ingredients-based methods, except for direct staff where a top-down approach was 
utilised to allocate the staff’s full salary to palliative care services. We collected costing data by 
conducting inventory audits, key informant interviews and observations. All inputs required in the 
production of the HBCPCS were checked against a costing framework for economic evaluations of 
palliative care interventions to ensure that the cost estimates were as inclusive as possible. All inputs 
with a lifespan of more than one year were annuitized using a 3% rate.  
Results  
The total annual cost for running the HBCPCS was R2 494 419 including both recurrent and capital 
costs. Recurrent items alone accounted for 96% (R2 392 407). While capital items accounted for 4% 
(R102 013) during the study period. The total cost per visit was R642 including the standard drug 
treatment package (R16). The major cost driver in the service was personnel accounting or 91% of the 
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total annual cost. While a scenario analysis shows that when the size of the team size is doubled then 
the cost of direct personnel would increase to R4.4 million. 
Conclusion 
We have estimated the incremental unit cost of HBCPCS to be R642 per visit, the major cost driver 
being personnel. If funding allows, with an annual cost of R2.4 million these services can be provided 
in a public tertiary hospital as an adjunct to inpatient care for patients as a strategy for integrating 
palliative care to general health care services, as has been done at GSH. The HBCPCS was less costly 
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In recent years we have seen a growing recognition of palliative care services in many regions of the 
world. However, in low- and middle-income countries there is limited data on access, availability, and 
utilization of palliative care interventions(1-3). This lack of evidence hinders the design and 
implementation of effective policies and health services that would serve palliative care patients(4). 
Palliative care has not been equitably integrated and funded like other health services, especially in 
Africa. It is now more than five years since the 67th World Health Assembly (WHA) where the World 
Health Organization (WHO) passed a resolution for governments to integrate palliative care services 
into the main health care services in their respective countries(5). South Africa published a National 
Policy Framework and Strategy on Palliative Care for the period 2017-2022, this strategy has 
demonstrated a commitment to palliative care. However, palliative care has not yet been integrated 
as per the WHO recommendation in South Africa(6). Furthermore, the burden of disease in South Africa 
makes it impossible to overlook palliative care services in the country(7, 8). Many patients continue to 
be discharged into the care of their families who are often not provided with the necessary support. 
This can result in patients not receiving the care they may need and places additional financial burden 
on families.  
 
The introduction of Universal Health Coverage (UHC) presents an ideal opportunity to redress and 
strengthen palliative care services in South Africa. Universal access for palliative care services 
continues to be scantily available and is often only a commodity of the wealthier in society. Across 
many African countries there are challenges and opportunities for the development of palliative care. 
Factors that augur well for the delivery of these services within the African region include the 
caregiving nature of communities, experience in dealing with chronic conditions such as tuberculosis 
(TB) and human immunodeficiency virus (HIV) and for some countries reasonably performing health 
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care systems. However, adequate funding has been perceived as the major challenge that impedes 
the integration of palliative care(9, 10). 
 
In South Africa deaths from non-communicable diseases increased progressively from 1997 to 2012 
and the top ten causes of mortality have not changed during this period(8). WHO mortality statistics 
reveal that non-communicable diseases are the leading cause of the deaths in South Africa, the broad 
cause of death by age shows that this disease category alone contribute up 65.77% to 67.82% for the 
age groups 55-74 and above 75 respectively which is a rate of 399.5 per 100 000 population for non-
communicable diseases in the period 2015-2019(11). In the Western Cape Province alone the mortality 
ratio due to non-communicable diseases and HIV was 1 in 5 patients admitted to medical wards and 
almost 1 in 10 patients admitted to surgical beds, with most patients dying within one year following 
their admission(12). The top mortality trends in the Western Cape Province are similar to the national 
disease profile in South Africa(12). The four disease categories that require palliative care most 
frequently are malignant neoplasms (28.2%), HIV diseases (22.2%) , cerebrovascular diseases (14.1%), 
dementias (12.2%)(13). Jointly the other conditions make up the remaining 23.3%(13). These statistics 
show a great need for palliative care interventions for the general population and especially for those 
patients who suffer from life limiting illnesses(12, 14). Palliative care aims to prevent and relieve pain 
and other distressing symptoms by means of impeccable assessment and management within a team 
which includes the patient’s family(15) The palliative care approach also integrates psychological and 
spiritual aspects of patient care, and very importantly a specialist provides support to the family during 
the patient’s illness and in bereavement. There is a perception of unaffordability, despite a lack of 
economic evaluation evidence for palliative care interventions. This can create a disregard of palliative 
care services which further creates inequities in health care delivery especially for those patients who 




Costing frameworks for palliative care interventions for the public sector in South Africa do not exist 
and the cost of running a comprehensive palliative care programme remains unknown. However, we 
have consulted guidelines such as the Global Health Cost Consortium Reference Case(16) to guide our 
cost estimation. To date there has not been much investment in performing costing studies in South 
Africa to assess the few palliative care domains being practised even during this window period of 
introduction of UHC in the country. We have only found one costing study undertaken for a hospital 
based outreach service in palliative care for a public provider(17), while other domains have not had 
published cost analyses. The aim of this study is to establish the incremental costs for hospital based 
consultative palliative care service (HBCPCS) in a tertiary facility in Cape Town, South Africa adopting 
a providers' perspective. Patient day equivalent (PDE) for tertiary and districts hospitals has been 
estimated elsewhere(18, 19), therefore findings of our study will add to this body of knowledge to 




Ethical approval for this study was obtained from the University of Cape Town Health Sciences’ Human 
Research Ethics Committee (HREC REF 521/2019). The study was conducted in the Western Cape 
Province of South Africa, at Groote Schuur Hospital (GSH) a tertiary academic public hospital. GSH had 
an annual capacity of 43 031 inpatient admissions and 417 234 outpatients visits, with 893 beds in use 
(approximately 81% bed occupancy)(20). There was an average of 525 doctors, 1 412 nurses and 268 
allied health professionals employed to serve patients during the study period. 
 
This study will only focus on the existing HBCPCS provided at GSH. The GSH palliative care team has 
been at the forefront in the development of the Western Cape palliative care policy which was 
launched in 2018. GSH including two other district hospitals are the only hospitals with operational 
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hospital based palliative care services in the province, servicing  eligible palliative care patients(21). 
HBCPCS is not an admitting ward but a team consulting to all inpatient wards within the hospital. 
These services provide a comprehensive palliative care assessment, discharge planning, pain and 
symptom control with the treatment team together with psycho-social and spiritual support. The 
teams also liaise and refer to community-based services, for instance home-based care and hospices, 
to ensure continuity of care for palliative care patients: organise family meetings for education and 
counselling and provide bereavement counselling to families. Further, the team facilitates follow up 
phone calls and refers patients to social services including providing palliative care mentorship for 
health care workers within their respective facilities. 
Data Collection 
 
We collected costing data for 2019 using three data collection techniques: inventory audits, key 
informant interviews observations and inventory audits. We interviewed key informants who are 
involved in the delivery of palliative care services in GSH to understand comprehensively the services 
they offer, the times they work and collate key assets that were used in delivery of palliative care 
services. Inventory audits were used by researchers together with the palliative care team to identify 
and quantify recurrent and capital items. Capital items included durable medical equipment, furniture, 
and administrative equipment; and recurrent items: consumables, administrative stationery, all of 
which are used in production of the palliative care service in GSH. We  identified, quantified and costed 
all inputs required in the production of HBCPCS including the cost of professional training for palliative 
care professionals (this is over and above their formal tertiary training such as their graduate and 
postgraduate degrees)(22). We used a fulltime equivalent at 40 hours a week to account for the time 
spent by the fulltime clinical health and allied professionals that were directly linked to the HBCPCS 
delivery: key informant interviews were also used to determine other materials required for delivery 
of palliative care services from the providers perspective, such as training (treated as a capital item), 
conferences and in-kind contributions such as the kitchenware, family room and boardroom 
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refurbishments.  Observations were used by the researcher to follow the patients journey throughout 
the palliative care trajectory to identify inputs in the production of the service. All inputs required in 
the production of the HBCPCS were checked against the Gardiner et al. 2017 Framework (a systematic 
review which assessed data from many countries such as Canada, The United States of America and 
the United Kingdom among others)(22) to ensure that the cost estimates were as inclusive as possible. 
No personal data was included, such as salary data linked to specific persons, instead we estimated 
the salaries using the 2018/19 department public services and administration (DPSA) salary 
appendices according to job specifications and employment levels(23). All identified assets were 
verified against the GSH main asset register compiled yearly by the asset department for management 
of assets.  All costs are presented in 2019 South African Rands.  
Data Analysis 
 
We used a mixed method approach to estimate the unit cost of providing a HBCPCS in a tertiary 
hospital adopting a public provider perspective to determine an incremental cost associated with the 
provision of the HBCPCS (the additional amount required for HBCPCS provided over and above the 
hospitalization costs associated with the patient’s admission). We developed a purpose-built costing 
tool in Microsoft Excel in consultation with palliative care specialists to estimate the cost of recurrent, 
capital and in-kind contributions in order to determine economic costs of delivering the HBCPCS in a 
tertiary public hospital. Recurrent items are those items with a life span of less than one year. While 
capital items are those items which have useful lives greater than one year. Capital items were 
annuitized using a rate of 3%(24). We estimate in-kind labour costs by calculating the number of hours 
personnel worked over a defined period, and then using the standard market rate based on seniority 
and region we calculated the cost of their contribution to the production of the service. To determine 
the cost of different staff complements, we have performed a scenario analysis comparing the current 
practise at GSH to scenarios where the size of the team is scaled-up(25, 26). For this study we only 
included patients that were assessed as eligible using the palliative care assessment tool, which in 
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2019 the total number of consultation or visits in the HBCPCS was 3985. This number denotes the 
denominator used for estimating the incremental unit cost. In the two broad categories of costs; 
recurrent and capital costs; researchers have identified ten categories of inputs for resources including 
a standard drug package (see Table 1). We compared the costs (see Appendix 7, Supplementary Table, 
Table 2 ) with the findings of a study conducted by Hongoro et al. in 2011(17), which uses a similar 
methodology and was conducted in South Africa. Therefore, there was no need for using purchasing 
power parity to adjust costs. We used the South African consumer price index (CPI) to inflate the costs 
to the year presented(27). 
Scenario Analysis 
 
The palliative team in GSH is comprised of a medical doctor, a clinical nurse practitioner (CNP), a 
professional nurse (PN), two social auxiliary workers and administrative personnel. We performed a 
scenario analysis to estimate the cost of direct staff, if the staff complement was altered in the 
following ways: In Scenario A we added one CNP and two PNs to the existing staff.  In Scenario B we 
added one GP, one CNP and one PN to the existing staff. While, in Scenario C we doubled the clinical 
staff number (i.e., two GPs, two CNPs, two PNs, four social auxiliary workers and one administrative 
personnel). 
Results 
In GSH there were 3 985 total palliative care encounters successfully conducted by the palliative care 
team between January and the end of December 2019.  Of these 1 027 were inpatients registered and 
cared for by the palliative care team over the period, while 1 482 encounters were repeat 
consultations for patients that were already registered and who needed a follow-up consultation in 
the same episode of admission. A total of 50 patients were readmitted to the hospital and 
subsequently registered for a second palliative care consultation while hospitalized in the second 
episode of admission. The team facilitated 700 family meetings and 726 phone call encounters to 
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follow-up with patients and to provide family support when patients were discharged making a total 
of 3985 encounters for the year 2019 (see Figure 1 below). 
 
Figure 1: Utilization of HBCPCS in GSH 
 
The total cost for running the HBCPCS was R2 494 419 accounting for both recurrent and capital costs. 
Recurrent items alone accounted for 96% (R2 392 407) of these costs (see Table 1). Personnel costs 
represented the greatest proportion of recurrent costs (91%) with direct personnel accounting for 
89%, indirect and volunteering personnel accounting for 3% of the total cost. Running costs which 
included transportation, consumables and stationery accounted for a total of 4%. Capital items 
accounted for 4% (R102 013) during the study period, these including durable medical equipment 
(0.2%), furniture (1%), training of the team (2%) and non-labour in-kind contribution (0.5%). Capital 
costs had items with a life expectancy of between two and ten years (depending on the item) and 
were amortized at a 3% rate. The cost of the total medication list for palliative care was R3 185 (i.e., if 
one was to use one of each of the medications that are routinely prescribed), while a standard 
treatment package was R16 (per individual). The total cost per visit was found to be R626 without 



















Table 1: Total annual cost by input 
Recurrent ZAR 2019 % 
 Personnel R2 281 887.74 91% 
     Direct Staff R2 213 079.00 89% 
     Indirect Staff R68 808.74 3% 
 Other R110 518.90 4% 
    Transportation R67 650.00 3% 
    Consumables R24 317.70 1% 
    Administration Stationary R18 551.20 1% 
Total Recurrent Cost R2 392 406.64 96% 
 Capital ZAR 2019   
    Durable Medical Equipment R4 443.30 0.2% 
    Furniture R28 208.46 1% 
    Training R58 024.05 2% 
    In-Kind Contributions Non-Labour R11 336.64 0.5% 
Total Capital Cost R102 012.45 4% 
Total Recurrent & Capital Cost R2 494 419.09   
 
Scenario Analysis 
The HBCPCS at GSH is team driven, direct staff constituted 89% of the total annual cost which 
represents R2.2 million. Direct staff are involved primarily in HBCPCS whereas indirect staff members 
are those who are in a supportive role to the palliative care team and constituted only 3% of the total 
annual cost. The results of the scenario analyses were as follows: Scenario A had a cost of R2.3 million; 
Scenario B had a cost close to R4 million; and Scenario C with double the number of the current 





Figure 2:  Scenario Analysis for staffing a HBCPCS. 
Discussion 
This study provides empirical evidence of the cost of consultative palliative care services in a tertiary 
public hospital in South Africa, the annual cost of this service being R2.4 million.  We are unable to 
compare our incremental cost per visit (R642) to the cost of hospitalisation for an average patient day 
equivalent (PDE), as our cost is per visit regardless of the number of days that an inpatient receives 
HBCPCS. However for interest the PDE adjusted for the national mix of district, regional and tertiary 
hospital in 2011 was R2 237(18), inflated at a rate of 1.4 this represents R3 212 in 2019 South African 
Rands. For district hospitals the average patient day equivalent is R1 543(19) (inflated with a consumer 
price inflation rate of 1.4). This in contrast to the general medical ward in a private hospital of 
approximately R 3 768 (a minimum rate per day of R3 600(28) inflated using a consumer price inflation 
of rate 1.04). However, there are notable structural differences between public and private health 
care which can make huge cost disparity accounted for by purchasing and staffing arrangements so it 
is likely our estimated unit cost per visit for HBPCS would be an underestimation for the private sector. 
Adding per day palliative care services to these hospital inpatient costs would increase overall cost of 
the PDE however we theorise that this model of integration would be less than adding and running a 





















establishing whether efforts to establish lower-cost, affordable palliative care that is satisfactory for 
patients is possible in South Africa(29). However, there is a need for a comprehensive economic 
evaluation in this field to investigate the cost effectiveness of palliative care strategies. Our findings, 
of a proportionally small incremental cost, are consistent with other costing studies HBCPCS seen in 
high income countries(30, 31), where palliative care services only has a small impact on the overall cost 
of hospitalization. However, research on palliative care shows that there is very limited evidence 
available for costing studies to compare with in Sub-Saharan Africa or LMICs generally(32). It is crucial 
to have HBCPCS attached to hospitals that service patients with advanced disease conditions(33), so 
that palliative care can be offered together with treatment from the beginning of the disease’s 
trajectory.  
 
The findings of this study determined the costs of HBCPCS in a public hospital which is intended to 
provide decision makers with cost evidence which will hopefully allow for the prioritization of HBCPCS 
for inpatients in public hospitals. Interventions in health care are not chosen based on their costs or 
even cost-effectiveness alone, consideration about the value these services add on patients’ lives is 
also necessary. Improved palliative care coverage should provide palliative care wherever patients are 
homes, communities and in hospitals. It is important to have these services for outpatients and home-
based patients, so that the needs of these patients are catered closer to where they reside. When 
dealing with a diverse population such as in South Africa, there is no one model that fits all individuals, 
especially when considering rolling out a comprehensive palliative care policy in a country with wider 
economic disparities. However, palliative care models should be evaluated for both cost and 
effectiveness where possible(34), in order to provide decision-makers with the necessary evidence to 
determine which strategies have the best outcomes and which the country can best afford. We cannot 
overlook palliative care in South Africa, considering both the burden of diseases, the financial loss 




Hospital based palliative care service are less costly than hospital-based outreach services. However, 
they are only accessible to a relatively small subset of the population(30, 38).  The GSH HBCPCS supports 
palliative care eligible patients who are admitted in this tertiary hospital, the team also supports 
families with the necessary tools when the patients are discharged and provides bereavement 
counselling when needed which are all invaluable and essential services.  The HBCPCS is not an 
admitting ward but rather a team of health and allied health professionals consulting to various wards 
within the hospital, and for this reason we have observed that personnel was a major cost driver for 
this service accounting for 91% of the total running costs. This study established an incremental 
costing of the HBCPCS at GSH, where we deliberately excluded infrastructure (mainly building costs) 
and overheads (such as water, electricity, and maintenance etc.) to establish a cost for running 
HBCPCS over and above the hospitalization costs. The total cost of running the service at GSH was R2.4 
million accounting for only 0.005% of the total national healthcare spending for the 2019/20 fiscal 
year(29-31, 39). 
The HBCPCS was less costly when compared to a similar strategy (HBOPCS) provided in Chris 
Baragwanath hospital in the Gauteng Province. The HBOPCS has an annual running cost of R11 
million(17), while, the findings of our study suggest that HBCPCS can delivered in a tertiary hospital with 
a cost of R2.4 million. Hongoro and Dinat’s (2011) cost analysis accounted for recurrent items only, 
which makes it comparable to our findings given that we have used an incremental costing technique. 
The differences in costs between these two studies (Hongoro et al. (2011) and ours) can be attributed 
to many reasons:  HBCPCS at GSH does not require intensive medical equipment; provides service to 
inpatients only; and the only major input in HBCPCS was personnel but even so the staff complement 
was smaller than the HBOPCS. The team in GSH was composed of one doctor, one clinical nurse 
practitioner, one professional nurse, two social auxiliary workers and one admin personnel. The 
composition of the team was working at full capacity, which contributed to the available staff being 
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overworked and sometimes some of the key functions of the services not being given the time and 
dedication they warrant such as education, research and training of other professionals within the 
hospital. The research component especially for economic evaluation of palliative care interventions 
has not been focused on in LMICs, as evidenced by the lack of published studies in the field in many 
African countries(32). While published research shows that there has been many attempts in 
establishing costing frameworks and in conducting cost-effectiveness and cost analysis for palliative 
care interventions in high income countries(39). 
 
As a larger team may be necessary to perform HBCPCS we conducted scenario analyses of several 
scaled-up options. As expected, when individuals higher in the organogram of HBCPCS are added to 
the team, the overall budgetary need is increased. These scenarios are based on ideal expert opinions. 
However, further studies are required to determine the best alternatives for staffing complement in 
the delivery of palliative care services. Calculating staffing requirements for specialized palliative care 
services is an intricate task and there is little literature published to suggest best practice. However, 
according to Henderson et al. (2019), staffing hospital that provides palliative care depends largely on 
the number of patient referrals and on expert opinion. They recommend at least one full time 
equivalent (FTE) registered nurse, one FTE physician and 0.5 FTE social worker for every 25 referrals 
in a single month(40). While, the Western Cape Policy and Strategy on Palliative Care proposes one 
dedicated palliative care specialist (academic posts), one or two dedicated doctors (medical officer 
level), five dedicated palliative care nurses, two social workers, five axillary social workers and an 
administrator(41). We are providing this cost information with the intension that decision makers will 
better understand the cost drivers, resources required and affordability of palliative care interventions 




Additional to direct staff there were other personnel who were not directly involved in the palliative 
care services such as occupational therapists, physiotherapists, dieticians, speech therapist, social 
workers, among others. Once the palliative care team carries out the palliative care assessment these 
personnel were often consulted occasionally to offer additional services to patients with palliative 
care needs. These staff are integral to the care given and only represent a small percentage of the 
overall cost (indirect staff accounted only for 3% of the total cost of the service). 
 
Furthermore, the palliative care team is given ad hoc training in palliative care to refresh and improve 
their knowledge. The auxiliary workers in the HBCPCS have been trained together with other 
personnel in palliative care to improve their competencies. This is a team of champions who provide 
mentorship to other institutions in the district, but if the team considers scaling up it would better to 
consider social workers instead since they would be on a same competency level and this would avoid 
training costs for auxiliary workers. It was necessary for this study to reflect the cost of training for 
professional staff understanding the value training has added to the quality of the services, it is 
through these investments that we see improved quality in services provision. Training has a critical 
significance in developing an adequately skilled workforce, training however accounted for only a 
small proportion of the total cost of the service (2%).   
 
The team also facilitated family meetings and performed follow-up phone calls to reintegrate the 
patients with their family while also ensuring that the family was able to provide the necessary support 
to be able to take care of their loved ones and felt supported themselves. Furthermore, 
recommendations and placements of patients to hospices was facilitated by the palliative care team 
in instances where the patients were not managed at home following their hospital discharge (21) . In 
2019 alone there were 58 patients that were placed in hospices, based on this number cost of 




Limited medical equipment was required for HBCPCS hence the proportion of the cost is low. In many 
medical interventions personnel and medical equipment are the major drivers for many services. 
However, in this service we have observed only personnel being the major cost driver as the medical 
and surgical wards are the holders of the larger medical equipment in the hospital and therefore a 
responsibility of the admitting ward since the palliative care team is consultatory. We formulated a 
standard prescription and costed this package separately so that it could be added subsequently to 
the unit cost of a HBCPCS visit, and easily changed if the medication or cost of medication changed 
dramatically. There was no treatment administered to patients directly by the team, instead the 
palliative care doctor writes a prescription which is given at the pharmacy based on availability. There 
is no substitute for HBCPCS within hospitals, the value they add to the patient’s quality of life is 
unmatched, and we have shown the monetary cost of this to be low. The GSH palliative care team has 
been an example to other institutions and in the forefront of the palliative care policy launch in the 
Western Cape.  
Limitations 
There have been challenges in accessing utilization data for palliative care patients, especially data 
about number of visits per patients which made it difficult for researchers to calculate average visits 
of patient. However, we feel that the approach used to estimate utilization is the most accurate for 
the research question posed. Researchers have purposively costed the hospital based consultative 
services as an incremental cost and have therefore excluded overheads of hospitalization cost to 
establish a cost of palliative care services over and above the inpatient costs. Some may see this as a 
limitation however it means that these unit costs can be easily added to known inpatient costs, as we 





HBCPCS are essential especially when linked to surgical, medical, oncology and other intensive care 
inpatient wards. These services may be provided alongside treatment to patients with chronic disease 
conditions to improve quality of life of these patients at the end of life. The role of the palliative care 
team extends beyond clinical care to further connecting these patients to ward based outreach teams 
and placing these patients in hospices. With an aging population and the observed disease burden in 
South Africa it is impossible to overlook palliative care.  Our findings shows that HBCPCS can be offered 
with just R2.4 million in one tertiary public hospital over a year, and with this cost these services can 
be offered simultaneously with other modalities of palliative care to provide a comprehensive 
approach of palliative care and to cater for patients in hospitals. This study provides the cost 
component of HBCPCS, paving a way for further research specifically cost analyses of palliative care 
interventions at different levels of care, as understanding the cost component can provide an 
opportunity for innovation in resource allocation. Adding on to this body of work we recommend a 
rigorous cost-effectiveness analysis for these interventions in low- and middle-income countries in 
order to better the value the options. 
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This policy brief reports the cost of providing a hospital based 
consultative palliative care service (HBCPCS) for a tertiary public hospital 
in South Africa. 
Key Findings  
 The palliative care team in Groote Schuur Hospital is composed of; one doctor, 
one clinical nurse practitioner, one professional nurse, two social auxiliary 
workers and one administrative personnel.  
 The role of palliative care team extends beyond clinical care to further connecting 
and placing patients to outreach teams and hospices following their hospital 
discharge.  
 There were 3 985 total patient consultations between January-December 2019. 
The total cost of this service was R2.4 million. Whilst, a cost per visit was R642 
including a standard drug package(1).  
 The total cost of running the HBCPCS accounted for only 0.005% of the total 
national healthcare spending for the 2019/20 fiscal year 
Introduction 
Given the burden of disease in South Africa and the World Health 
Organization (WHO) recommendation to integrate palliative care services 
we cannot overlook palliative care services. The Sub-Saharan region has 
sparse established palliative care to cater to people with complex 
symptoms due to life-limiting conditions or terminal illnesses. Palliative 
care aims to enhance and preserve quality of life for patients and their 
loved ones and encourages them to live as actively as possible while they 
are alive.  
The top mortality trends in the Western Cape Province (WC) resonate with 
the burden of disease profile in South Africa generally(2). Considering the 
window of opportunity presented by the introduction of universal health 
coverage and the burden of disease faced in the region, it is now an 
opportune moment to grant palliative care the recognition it deserves. 
These statistics show a great need for palliative care interventions for the 
general population and especially for those patients who suffer from life 
limiting-illnesses.  
Methodology 
The study was conducted in the WC, at Groote Schuur Hospital (GSH) a 
teaching tertiary-level public hospital. We have used a mixed method to 
estimate the incremental unit cost of providing HBCPCS adopting a public 
provider’s perspective. We costed recurrent and capital items used in the 
production of the HBCPCS, a combination of assets inventory, key 
informant interviews and observations were used to collect this empirical 
costing data. These costs were captured for the 2018/19 fiscal year and 
included the annual operational cost and cost per visit for the service. The 
cost of capital items (with a life expectancy exceeding one year) were 
annuitized using a 3% rate and combined with recurrent cost to establish 
the incremental cost of HBCPCS (above the cost of hospitalization). 
Findings 
The major cost driver in the HBCPCS was direct personnel which accounted 
for 91% of the total cost. This finding mirrored what was happening on the 
ground, the service is not an admitting ward but rather a team of health 
professionals consulting in various wards within the hospital. When we 
performed a scenario analysis for scaling-up options, we have observed 
that doubling the number of the clinical and allied staff would increase the 
cost to R4.4 million. The findings of this study shows that one HBCPCS 
accounted for 0.005% of the total national healthcare spending for the 
2019/20 fiscal year. 
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Table 1: Total annual cost by input 
Recurrent ZAR 2019 % 
 Personnel R2 281 887.74 91% 
   Direct Staff R2 213 079.00 89% 
   Indirect Staff R68 808.74 3% 
 Other R110 518.90 4% 
   Transportation R67 650.00 3% 
   Consumables R24 317.70 1% 
   Administration Stationary R18 551.20 1% 
Total Recurrent Cost R2 392 406.64 96% 
 Capital ZAR 2019   
   Durable Medical Equipment R4 443.30 0.2% 
   Furniture R28 208.46 1% 
Training R58 024.05 
2% 
   In-kind Contributions Non-labour R11 336.64 0.5% 
Total Capital Cost R102 012.45 4% 
Total Recurrent & Capital Cost R2 494 419.09   
 
When we compared this service (HBCPCS) to a hospital based outreach 
palliative care services (HBOPCS)(3), we observed that HBCPCS is less 
expensive. HBCPCS are essential especially when linked to; surgical, 
medical, oncology and other intensive care inpatient wards. While, these 
inpatient services improve health, palliative care improves dignity and 
quality of life for patients facing life-limiting conditions, and their families. 
There were notable vacancies in the structure of the team, which 
contributed to the available staff being overworked and sometimes some 
of the key functions of the services being overlooked such as research into 
palliative care and training of other staff. Furthermore, this team provides 
mentorship to other institutions in the province and they have played a 
vital role in the development of the proposed model for the 
implementation of palliative care policy in the WC. The role of the palliative 
care team extends beyond clinical care to further connecting these 
patients to ward based outreach teams and placing these patients in 
hospices for continuity of care, the team also supports families; teaches 
them how to care for their loved ones; and provides bereavement 
counselling. These finding show that HBCPCS are potentially of low cost 
when run in a public tertiary hospital and may be of huge benefit to 
patients and their families. 
Recommendations  
HBCPCS can be offered simultaneously with other modalities of palliative 
care to provide a comprehensive approach which caters to patients with 
life-limiting conditions or terminal illnesses. It is crucial to provide HBCPCS 
in hospitals that service patients with advanced disease conditions, so that 
palliative care can be offered together with treatment from the beginning 
of the disease’s trajectory. Given the low proportion of the HBCPCS to the 
national healthcare expenditure, this modality can be provided in other 
tertiary facilities within the country. 
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Appendix 4: Written informed consent for Key Informant Interviews 
 
The cost of providing consultative palliative care services in a tertiary hospital setting 
 
This study is conducted by Linda Mbuthini from the University of Cape Town, Health Economics Unit, School of public 
health and family medicine, for a master’s dissertation with the possibility to publish results in the future. 
The purpose of the study is to determine the costs and cost drivers for hospital based consultative palliative care 
service (HBPCS) in South Africa adopting a providers' perspective. Once the cost evidence has been established it 
may be used by decision makers to advocate for the integration of palliative care services in the general health care 
services. 
Key informants who work in palliative care unit at Grote Schuur Hospital who give informed consent will take part in 
the study in order to give information regarding working times, general services and patients’ palliative care needs. 
Questions will be asked, and the answers will be recorded in the Microsoft excel spreadsheet tool. The interviews 
will take approximately 1 hour. There will be no follow up interview. 
Participants may withdraw from the study at any stage. Feedback of results will be available to participants on 
request. There will be no risks, benefits nor cost involved for the participants in this study. There is no insurance 
cover for participants in this study as there are no anticipated harm. 
 
Ethical approval for this study has been secured from The Faculty of Health Sciences Human Research Ethics 
Committee. All the research will adhere to the Declaration of Helsinki 2008. Participants can contact the Human 
Research Ethics Committee if there are any questions about their rights and welfare as research subjects. 
If there are any further questions with regards to the study feel free to contact Linda Mbuthini 
MBTLIN006@myUCT.ac.a or cell number 0833100391. 
 
I ___________________________have read the information sheet  
(or it has been read to me by ______________________).  
 
I understand what is required of me and I have had all my questions answered. I do not feel that I am forced to 
take part in this study and I am doing so of my own free will. I know that I can withdraw at any time if I so wish 
without any repercussions. 
Signed: _______________________________________ 
Participant: _______________________ Date and place: _________________ 
Researcher: _______________________ Date and place: _________________ 
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Appendix 7: Supplementary Table 
Table 2: Supplementary table- Total Recurrent Costs by Line Item (2019) HBCPCS vs HBPCOP 
HBCPCS Groote Schuur 
Recurrent Items ZAR 2019 % 
     Direct Staff R2 213 079.00 93% 
     Indirect Staff R68 808.74 3% 
     Transportation R67 650.00 3% 
     Consumables R24 317.70 1% 
     Administration Stationary R18 551.20 1% 
Total R2 392 406.64 
HBPCOP Chris Baragwanath Hongoro et.al 2011 
Recurrent Items USD 2007 % 
     Personnel $441 991.50 63% 
     Costs and expenses $102 455.31 15% 
     Project costs $87 373.97 12% 
     Management support services $70 201.09 10% 
Total $702 021.87 
Total HBPCOP ZAR 2019* R11 063 864.67 
Cost per visit 
Total Encounters Cost Per visit 
HBCPCS 3985 R600.35 
HBPCOP 7905 R1 399.60 
Total Cost using standard number of encounters 
HBCPCS 5945 R402.42 
HBPCOP 5945 R1 861.04 
*(CPI 2019/CPI 2007)= (112/57)=1.97;
Currency exchange in 2007 1 USD is equal 8 ZAR =$702 021.87*8 =R5 616 174.96; 
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http://www.controlled-trials.com (see http://www.clinicaltrials.gov for guidance concerning the 
types of trials that must be registered). The maximum length for Original Articles is 3500 words (not 
including Abstract or references) and the text should be divided into sections with the headings 
Abstract (see below), Introduction, Methods, Results, Discussion, Disclosures and Acknowledgments, 
and References. In the Methods section of an article describing a clinical trial, please include a 
statement about where the registration information is available. 
Brief Reports may describe research studies of any type or design. The section is appropriate       for 
work that can be described succinctly, often because it is preliminary, largely confirmatory, or limited 
by its design or methodology. Articles that describe clinical trials should generally comport with the 
Consolidated Standards of Reporting Trials (CONSORT) Statement and guidelines (see www.consort-
statement.org and its links). Clinical trials also must be registered at an accepted online repository 
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Acknowledgments, and References. 
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Lessons Learned. 
Clinical Notes are case series or small observational studies describing new or interesting clinical 
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Palliative Care Rounds couple a case description that includes an important clinical observation with 
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